British Society for Gene and Cell Therapy (BSGCT)

Description

The aim of the British Society for Gene Therapy is to accelerate scientific progress and promote ethical and efficient transfer of gene- and cell-based technologies from the laboratory into the clinic.  The Aim is to ccelerate scientific progress and promote ethical and thorough transfer of gene- and cell-based technologies from the laboratory into the clinic, for treatment of a range of serious disorders, including cancer, heart disease and monogenic disorders. BSGT will facilitate this progress by: Promoting communication and the free flow of information between UK scientists, leading to better collaborations and the sharing of knowledge and resources. Providing a forum for specialised scientific debate in the field of cell- and gene-based treatments, particularly to enhance the education of younger scientists and clinicians. Improving the interaction between scientists and clinicians, to enhance thorough science-led and ethical evaluation of new technologies in the clinic. Improving public awareness and providing an informed and responsible voice for science in this field. Improving the productivity of gene and cell therapy research in the UK, moving innovations forward from the laboratory for clinical study as soon as it is appropriate. Developing strong links with donors and funding bodies, aiming together to build on the scientific infrastructure that already exists in the UK.

Organisation's Type

Scientific Society